New study tests app and group classes to keep Seniors' minds sharp
NCT ID NCT07141160
First seen Jan 07, 2026 · Last updated Jun 23, 2026 · Updated 28 times
Summary
This study tests a program called ADL+2.0 that combines a mobile app with group activities to prevent cognitive decline in adults aged 60 and older who have memory concerns. The program includes cognitive training, exercises, and wellness tips, delivered remotely or in person. Researchers will compare three groups to see if the program improves thinking skills, quality of life, and is cost-effective.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COGNITIVE DECLINE are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Tan Tock Seng Hospital
Singapore, Singapore
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Mobile app and group-based cognitive health program
What this could lead to
If successful, this could provide a scalable, cost-effective way to delay or prevent cognitive decline in older adults, reducing dementia risk.
What could go wrong
This is an early-stage study with 255 participants, so results may not apply broadly. The intervention relies on user engagement, and benefits may be modest or not sustained.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.